Compare IMVT & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMVT | MGY |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.1B |
| IPO Year | 2019 | 2017 |
| Metric | IMVT | MGY |
|---|---|---|
| Price | $31.22 | $27.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | ★ $33.00 | $30.36 |
| AVG Volume (30 Days) | ★ 2.4M | 2.1M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $1,311,845,000.00 |
| Revenue This Year | N/A | $14.65 |
| Revenue Next Year | N/A | $1.99 |
| P/E Ratio | ★ N/A | $117.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.32 | $21.07 |
| 52 Week High | $36.29 | $32.76 |
| Indicator | IMVT | MGY |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 40.91 |
| Support Level | $22.84 | $26.91 |
| Resistance Level | $36.29 | $30.90 |
| Average True Range (ATR) | 1.95 | 0.75 |
| MACD | -0.20 | -0.08 |
| Stochastic Oscillator | 50.26 | 12.43 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).